Expert Insights

Explore practical guidance to help medical technology teams reduce risk, make informed decisions, and bring life-changing products to patients faster.
New Guidance Released on EU MDR Vigilance Terms and Concepts
blocks spelling out guidance
EU

New Guidance Released on EU MDR Vigilance Terms and Concepts

March 2, 2023 5 min read
EMA Scientific Advice Pilot for Firms Seeking EU MDR Approval – What Does This Pilot Mean for Medical Device Companies?
european union flag flying next to building
EU

EMA Scientific Advice Pilot for Firms Seeking EU MDR Approval – What Does This Pilot Mean for Medical Device Companies?

March 2, 2023 3 min read
US Reimbursement for Medical Device and IVDs – What Startups Should Know
reimbursement paper next to calculator

US Reimbursement for Medical Device and IVDs – What Startups Should Know

February 10, 2023 3 min read
Guidance on the Health Institution Exemption Under Article 5(5) of EU MDR and EU IVDR
doctor using tablet in medical room
EU

Guidance on the Health Institution Exemption Under Article 5(5) of EU MDR and EU IVDR

February 2, 2023 3 min read
VALID Act Fails to Pass – What to Expect for the Future of LDT Regulation
circle with slash through it over the valid act next to gavel

VALID Act Fails to Pass – What to Expect for the Future of LDT Regulation

January 23, 2023 2 min read
Understanding FDA’s New Guidance Document on Human Factors Information in Medical Device Submissions
diagram

Understanding FDA’s New Guidance Document on Human Factors Information in Medical Device Submissions

January 18, 2023 5 min read
Understanding FDA’s Draft Guidance Document on Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers
voluntary malfunction summary report word cloud

Understanding FDA’s Draft Guidance Document on Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers

January 13, 2023 4 min read
European Union Clinical Trials Regulation: Mandatory Deadline Approaching
deadline ahead with an alarm clock

European Union Clinical Trials Regulation: Mandatory Deadline Approaching

December 20, 2022 3 min read
Part 3 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December
part 3 aligning FDA regulations with the common rule

Part 3 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December

December 12, 2022 4 min read

Patients Are Waiting.

Every submission, study, inspection, and commercialization decision moves a patient closer to the technology they're waiting for. Partner with Medicept to navigate every milestone with clarity, continuity, and confidence.